Skip to main content

CITADEL ADVISORS LLC

Position in LH — Labcorp Holdings Inc.

CIK 1423053 MIAMI, FL

Position in LH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,902,760
-$9,131,198 QoQ
Shares Held
35,367
-50.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#174
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LH Over Time

Shares Held

Position Value (USD)

Derivatives in LH

reported options exposure · as of Jun 30, 2026
CallValue
$7,112,000
CallShares
25,400
PutValue
$13,412,000
PutShares
47,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,783,709,630 across 35 Diagnostics & Research names. LH ranks #18 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,412,000 47,900
2026-06-30 $7,112,000 25,400
2026-06-30 $9,902,760 35,367
2026-03-31 $8,564,601 32,100
2026-03-31 $19,033,958 71,339
2026-03-31 $1,254,007 4,700
2025-12-31 $7,024,640 28,000
2025-12-31 $3,261,440 13,000
2025-12-31 $37,204,499 148,296
2025-09-30 $148,281,990 516,554
2025-09-30 $12,343,580 43,000
2025-09-30 $3,502,132 12,200
2025-06-30 $10,421,647 39,700
2025-06-30 $36,818,602 140,256
2025-06-30 $7,770,296 29,600
2025-03-31 $2,094,660 9,000
2025-03-31 $14,592,798 62,700
2025-03-31 $537,163 2,308
2024-12-31 $328,024,143 1,430,421
2024-12-31 $24,330,852 106,100
2024-12-31 $3,233,412 14,100
2024-09-30 $15,420,120 69,000
2024-09-30 $11,039,912 49,400
2024-09-30 $29,912,350 133,848
2024-06-30 $9,748,129 47,900
2024-06-30 $14,957,985 73,500